LLYON
li Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes.
NameLLYON
RankNo.1329
Market Cap$0.00
Fully Diluted Market Cap$0.00
Market Share%
Trading Vol/Market Cap (24H)33,367.89%
Circulation Supply4,167.01368225
Max Supply0
Total Supply4,167.01368225
Circulation Rate%
Issue Date--
The price at which the asset was first issued--
All-Time High1122.2109786358383,2026-01-08
Lowest Price712.8133541417105,2025-09-25
Public BlockchainETH
Introductionli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes.
Sector
Social Media
etfindex:mc_etfindex_sourceDisclaimer: Data provided by cmc and should not be considered as investment advice.
